Anti-Inflammatory drug colchicine tested to boost insulin sensitivity in type 1 diabetes
NCT ID NCT07247734
First seen Jan 09, 2026 · Last updated May 24, 2026 · Updated 23 times
Summary
This study tests whether colchicine, an anti-inflammatory drug, can improve how well the body responds to insulin in people with type 1 diabetes who have low-grade inflammation. Researchers will measure insulin sensitivity using a special test. The trial involves 26 adults and compares colchicine to a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Capital Region 2900
RECRUITINGGentofte Municipality, 2400, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.